Literature DB >> 10780334

Recombinant factor VIIa for bleeding in refractory thrombocytopenia.

B Vidarsson, P T Onundarson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780334

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

Review 1.  The use of recombinant activated coagulation factor VII for spine surgery.

Authors:  Richard B Weiskopf
Journal:  Eur Spine J       Date:  2004-05-25       Impact factor: 3.134

Review 2.  Recombinant factor VIIa: a review on its clinical use.

Authors:  Massimo Franchini
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

Review 3.  The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

4.  Recombinant factor VIIa is an effective therapy for abdominal surgery and severe thrombocytopenia: a case report.

Authors:  Venancio Conesa; Andrés Navarro-Ruiz; Joaquín Borrás-Blasco; Angela Mompel; Amparo Gómez; Mercedes González
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

Review 5.  The emerging role of recombinant-activated factor VII in neurocritical care.

Authors:  Matthew E Fewel; Paul Park
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.